FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

François Alhenc-Gelas

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Kidneys

Concepts & Ideas

Genes & Molecular Sequences

Amino Acid Sequences

Physiology

Genotype

Disorders

Co-author Network

Publications

TOP 3
Ludovic Waeckel; François Alhenc-Gelas; Patrick Bruneval; Catherine Chollet; Louis Potier; Ronan Roussel; Christopher Taveau; Nadine Bouby
Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse.
Gaia Spinetti; Orazio Fortunato; Daniela Cordella; Paola Portararo; Nicolle Kraenkel; Rajesh G Katare; Graciela B Sala-Newby; Christine Richer; Marie-Pascale Vincent; François Alhenc-Gelas; Giancarlo Tonolo; Sara Cherchi; Costanza Emanueli; Paolo Madeddu
Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.
François Alhenc-Gelas; Nadine Bouby; Louis Potier; Christine Richer; Ronan Roussel; Michel Marre
Kinins as therapeutic agents in cardiovascular and renal diseases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of François Alhenc-Gelas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ludovic Waeckel; François Alhenc-Gelas; Patrick Bruneval; Catherine Chollet; Louis Potier; Ronan Roussel; Christopher Taveau; Nadine Bouby
Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse.
Endocrinology 2012;153(8):3886-96.
2011: Gaia Spinetti; Orazio Fortunato; Daniela Cordella; Paola Portararo; Nicolle Kraenkel; Rajesh G Katare; Graciela B Sala-Newby; Christine Richer; Marie-Pascale Vincent; François Alhenc-Gelas; Giancarlo Tonolo; Sara Cherchi; Costanza Emanueli; Paolo Madeddu
Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.
Circulation research 2011;108(3):284-93.
2011: François Alhenc-Gelas; Nadine Bouby; Louis Potier; Christine Richer; Ronan Roussel; Michel Marre
Kinins as therapeutic agents in cardiovascular and renal diseases.
Current pharmaceutical design 2011;17(25):2654-62.
2010: Erij Messadi; Marie-Pascale Vincent; Violaine Griol-Charhbili; Chantal Mandet; Juliana Colucci; John H Krege; Patrick Bruneval; Nadine Bouby; Oliver Smithies; François Alhenc-Gelas; Christine Richer
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(12):4691-700.
2009: Violaine Griol-Charhbili; Laurent Sabbah; Juliana Colucci; Marie-Pascale Vincent; Véronique Baudrie; Dominique Laude; Jean-Luc Elghozi; Patrick Bruneval; Nicolas Picard; Pierre Meneton; François Alhenc-Gelas; Christine Richer
Tissue kallikrein deficiency and renovascular hypertension in the mouse.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;296(5):R1385-91.
2009: Oliver A Stone; Christine Richer; Costanza Emanueli; Vincent van Weel; Paul H A Quax; Rajesh Katare; Nicolle Kraenkel; Paola Campagnolo; Luciola S Barcelos; Mauro Siragusa; Graciela B Sala-Newby; Danila Baldessari; Marina Mione; Marie P Vincent; Andrew V Benest; Ayman Al Haj Zen; Julien Gonzalez; David O Bates; François Alhenc-Gelas; Paolo Madeddu
Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(5):657-64.
2008: Samy HADJADJ; Frédéric Fumeron; Ronan Roussel; Pierre-Jean Saulnier; Yves Gallois; Amos Ankotche; Florence Travert; Charbel Abi Khalil; Aurélie Miot; François Alhenc-Gelas; Michel Lievre; Michel Marre
Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.
Diabetes care 2008;31(9):1847-52.
2008: Anne Pizard; Christine Richer; Nadine Bouby; Nicolas Picard; Pierre Meneton; Michel Azizi; François Alhenc-Gelas
Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.
Biological chemistry 2008;389(6):701-6.
2008: Joëlle Gardes; Stéphanie Michineau; Anne Pizard; François Alhenc-Gelas; Rabary M Rajerison
Aspirin inhibits human bradykinin B2 receptor ligand binding function.
Biochemical pharmacology 2008;75(9):1807-16.
2008: Sandrine Pons; Violaine Griol-Charhbili; Christophe Heymes; Paul Fornes; Didier Heudes; Albert Hagege; Xavier LOYER; Pierre Meneton; Jean-François Giudicelli; Jane-Lise Samuel; François Alhenc-Gelas; Christine Richer
Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice.
European journal of heart failure 2008;10(4):343-51.
2008: Michel Azizi; Costanza Emanueli; Séverine Peyrard; Paolo Maddedu; François Alhenc-Gelas; Duncan J Campbell
Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man.
Journal of hypertension 2008;26(4):714-20.
2008: E Messadi-Laribi; Violaine Griol-Charhbili; E Gaies; M P Vincent; Didier Heudes; Pierre Meneton; François Alhenc-Gelas; Christine Richer
Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Clinical and experimental pharmacology & physiology 2008;35(4):489-93.
2007: Marie Briet; Cédric Collin; Stéphane Laurent; Alice Tan; Michel Azizi; Mohsen Agharazii; Xavier Jeunemaitre; François Alhenc-Gelas; Pierre Boutouyrie
Endothelial function and chronic exposure to air pollution in normal male subjects.
Hypertension 2007;50(5):970-6.
2007: Erij Messadi-Laribi; Violaine Griol-Charhbili; Anne Pizard; Marie-Pascale Vincent; Didier Heudes; Pierre Meneton; François Alhenc-Gelas; Christine Richer
Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia.
The Journal of pharmacology and experimental therapeutics 2007;323(1):210-6.
2007: Anne Blanchard; Michel Azizi; Séverine Peyrard; Nora Stern; François Alhenc-Gelas; Pascal Houillier; Xavier Jeunemaitre
Partial human genetic deficiency in tissue kallikrein activity and renal calcium handling.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(2):320-5.
2006: Paolo Madeddu; Costanza Emanueli; Frank Spillmann; M Meloni; Nadine Bouby; Christine Richer; François Alhenc-Gelas; Vincent van Weel; Daniel Eefting; Paul H A Quax; Y Hu; Q Xu; A L Hemdahl; Jolanda van Golde; M Huijberts; Q de Lussanet; H Struijker Boudier; thierry couffinhal; C Duplaa; S Chimenti; Lidia Staszewsky; R Latini; V Baumans; B I Levy
Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems.
Vascular pharmacology 2006;45(5):281-301.
2006: Edward Shesely; Chun-Bo Hu; François Alhenc-Gelas; Pierre Meneton; Oscar Carretero
A second expressed kininogen gene in mice.
Physiological genomics 2006;26(2):152-7.
2006: Stéphanie Michineau; François Alhenc-Gelas; Rabary M Rajerison
Human bradykinin B2 receptor sialylation and N-glycosylation participate with disulfide bonding in surface receptor dimerization.
Biochemistry 2006;45(8):2699-707.
2005: Nicolas Picard; Monique Van Abel; Christelle Campone; Michelle Seiler; May Bloch-Faure; Joost G J Hoenderop; Johannes Loffing; Pierre Meneton; René J M Bindels; Michel Paillard; François Alhenc-Gelas; Pascal Houillier
Tissue kallikrein-deficient mice display a defect in renal tubular calcium absorption.
Journal of the American Society of Nephrology : JASN 2005;16(12):3602-10.
2005: Laurent Weekers; Beatrice Bouhanick; Samy HADJADJ; Yves Gallois; Ronan Roussel; Franck Pean; Amos Ankotche; Gilles Chatellier; François Alhenc-Gelas; Pierre J Lefebvre; Michel Marre
Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.
Diabetes 2005;54(10):2961-7.
2005: Christophe Griffon; Nelly Boehm; J Allegrini; Anne Miternique; François Alhenc-Gelas; Philippe Hudlett; Dominique Stephan
[Gene transfers of kallikrein, bradykinin receptor B2 and a mutated B2 receptor stimulate neoangiogenesis in peripheral ischemia].
Archives des maladies du coeur et des vaisseaux 2005;98(7-8):825-9.
2005: Violaine Griol-Charhbili; E Messadi-Laribi; J L Bascands; Didier Heudes; Pierre Meneton; Jean-François Giudicelli; François Alhenc-Gelas; Christine Richer
Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(9):1172-4.
2005: Michel Azizi; Pierre Boutouyrie; François Alhenc-Gelas; Stéphane Laurent; Xavier Jeunemaitre
[Polymorphism of kallikrein gene and abnormalities of the endothelial function].
Médecine sciences : M/S 2005;21(6-7):584-5.
2005: Michel Azizi; Pierre Boutouyrie; Alvine Bissery; Mohsen Agharazii; Francis H Verbeke; Nora Stern; Alessandra Bura-Rivière; Stéphane Laurent; François Alhenc-Gelas; Xavier Jeunemaitre
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans.
The Journal of clinical investigation 2005;115(3):780-7.
2004: Erwan Bozec; Patrick Lacolley; Sonia Bergaya; Pierre Boutouyrie; Pierre Meneton; Monique Herissé-Legrand; Chantal M Boulanger; François Alhenc-Gelas; Hyung-Suk Kim; Stéphane Laurent; Hubert Dabiré
Arterial stiffness and angiotensinogen gene in hypertensive patients and mutant mice.
Journal of hypertension 2004;22(7):1299-307.
2004: Sonia Bergaya; Rob H P Hilgers; Pierre Meneton; You Dong; May Bloch-Faure; Tadashi Inagami; François Alhenc-Gelas; Bernard I Lévy; Chantal M Boulanger
Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
Circulation research 2004;94(12):1623-9.
2003: Claudia M B Helou; Martine Imbert-Teboul; Alain Doucet; Rabary M Rajerison; Catherine Chollet; François Alhenc-Gelas; Jeannine Marchetti
Angiotensin receptor subtypes in thin and muscular juxtamedullary efferent arterioles of rat kidney.
American journal of physiology. Renal physiology 2003;285(3):F507-14.
2003: Samy HADJADJ; Yves Gallois; François Alhenc-Gelas; G Chatellier; M Marre; Nathalie Genes; Michel Lievre; J Mann; J Menard; D Vasmant
Angiotensin-I-converting enzyme insertion/deletion polymorphism and high urinary albumin concentration in French Type 2 diabetes patients.
Diabetic medicine : a journal of the British Diabetic Association 2003;20(8):677-82.
2003: Jeannine Marchetti; Claudia M B Helou; Catherine Chollet; Rabary M Rajerison; François Alhenc-Gelas
ACE and non-ACE mediated effect of angiotensin I on intracellular calcium mobilization in rat glomerular arterioles.
American journal of physiology. Heart and circulatory physiology 2003;284(6):H1933-41.
2002: Fabien Trabold; Sandrine Pons; Albert A Hagege; May Bloch-Faure; François Alhenc-Gelas; Jean-François Giudicelli; Christine Richer-Giudicelli; Pierre Meneton
Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice.
Hypertension 2002;40(1):90-5.
2002: Rola Slim; Florence Torremocha; Thierry Moreau; Anne Pizard; Steven C Hunt; Albert Vuagnat; Gordon H Williams; Francis Gauthier; Xavier Jeunemaitre; François Alhenc-Gelas
Loss-of-function polymorphism of the human kallikrein gene with reduced urinary kallikrein activity.
Journal of the American Society of Nephrology : JASN 2002;13(4):968-76.
2001: Anne Pizard; Andree Blaukat; Stéphanie Michineau; Ivan Dikic; W Müller-Esterl; François Alhenc-Gelas; Rabary M Rajerison
Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy.
Biochemistry 2001;40(51):15743-51.
2001: W Huang; Yves Gallois; Nadine Bouby; Patrick Bruneval; Didier Heudes; Marie-France Belair; John Krege; Pierre Meneton; Michel Marre; Oliver Smithies; François Alhenc-Gelas
Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(23):13330-4.
2001: Andree Blaukat; Anne Pizard; A Breit; Christer Wernstedt; François Alhenc-Gelas; W Muller-Esterl; Ivan Dikic
Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function.
The Journal of biological chemistry 2001;276(44):40431-40.
2001: Sonia Bergaya; Pierre Meneton; May Bloch-Faure; Eric Mathieu; François Alhenc-Gelas; Bernard I Lévy; Chantal M Boulanger
Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice.
Circulation research 2001;88(6):593-9.
2001: Samy HADJADJ; R Belloum; Beatrice Bouhanick; Yves Gallois; G Guilloteau; Gilles Chatellier; François Alhenc-Gelas; Michel Marre
Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study.
Journal of the American Society of Nephrology : JASN 2001;12(3):541-9.
2001: Pierre Meneton; May Bloch-Faure; Albert A Hagege; Hartmut Ruetten; W Huang; Sonia Bergaya; D Ceiler; Doris Gehring; I Martins; G Salmon; Chantal M Boulanger; J Nussberger; Bertrand Crozatier; Jean-Marie Gasc; Didier Heudes; Patrick Bruneval; Thomas Doetschman; Joël Ménard; François Alhenc-Gelas
Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2634-9.
2001: Jeannine Marchetti; Françoise Praddaude; Rabary M Rajerison; Jean-Louis Ader; François Alhenc-Gelas
Bradykinin attenuates the [Ca(2+)](i) response to angiotensin II of renal juxtamedullary efferent arterioles via an EDHF.
British journal of pharmacology 2001;132(3):749-59.
2000: Folker E Franke; Katharina Pauls; L Kerkman; Klaus Steger; Thomas Klonisch; R Metzger; François Alhenc-Gelas; Eberhard Burkhardt; Martin Bergmann; Sergei M Danilov
Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors.
Human pathology 2000;31(12):1466-76.
2000: François Alhenc-Gelas
[The renin-angiotensin system and progression of kidney disease].
Presse médicale (Paris, France : 1983) 2000;29(14):806-10.
1999: Françoise Praddaude; Jeannine Marchetti; François Alhenc-Gelas; Jean-Louis Ader
Dissimilar mechanisms of Ca(2+) response to bradykinin in different types of juxtamedullary glomerular arterioles.
The American journal of physiology 1999;277(5 Pt 2):F697-705.
1999: R Metzger; R M Bohle; Katharina Pauls; G Eichner; François Alhenc-Gelas; Sergei M Danilov; Folker E Franke
Angiotensin-converting enzyme in non-neoplastic kidney diseases.
Kidney international 1999;56(4):1442-54.
1999: Andree Blaukat; Anne Pizard; Rabary M Rajerison; François Alhenc-Gelas; W Müller-Esterl; Ivan Dikic
Activation of mitogen-activated protein kinase by the bradykinin B2 receptor is independent of receptor phosphorylation and phosphorylation-triggered internalization.
FEBS letters 1999;451(3):337-41.
1999: Anne Pizard; Andree Blaukat; W Müller-Esterl; François Alhenc-Gelas; Rabary M Rajerison
Bradykinin-induced internalization of the human B2 receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail.
The Journal of biological chemistry 1999;274(18):12738-47.
1999: Michel Marre; Beatrice Bouhanick; Gilles Berrut; Yves Gallois; Jean-Jacques Le Jeune; Gilles Chatellier; J Menard; François Alhenc-Gelas
Renal changes on hyperglycemia and angiotensin-converting enzyme in type 1 diabetes.
Hypertension 1999;33(3):775-80.
1998: O Costerousse; J Allegrini; Jean-Paul Clozel; Joël Ménard; François Alhenc-Gelas
Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
The Journal of pharmacology and experimental therapeutics 1998;284(3):1180-7.
1998: Anne Pizard; Jeannine Marchetti; J Allegrini; François Alhenc-Gelas; Rabary M Rajerison
Negative cooperativity in the human bradykinin B2 receptor.
The Journal of biological chemistry 1998;273(3):1309-15.
1998: Pierre Meneton; François Alhenc-Gelas
[Experimental genetic modifications in the renin-angiotensin and kallikrein-kinin systems: significance for understanding cardiovascular regulation and study of genetic determinism of human diseases].
Néphrologie 1998;19(7):385-9.
1998: O Costerousse; J Allegrini; W Huang; François Alhenc-Gelas
Angiotensin I-converting enzyme (kininase II) in cardiovascular and renal regulations and diseases.
Biological research 1998;31(3):161-7.
1997: O Costerousse; Sergei M Danilov; François Alhenc-Gelas
Genetics of angiotensin I-converting enzyme.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1997;19(5-6):659-69.
1997: Werner Haberbosch; Rainer M Bohle; Folker E Franke; Sergei M Danilov; François Alhenc-Gelas; Ruediger C Braun-Dullaeus; Hans Hölschermann; Wolfgang Waas; Harald Tillmanns; Andreas Gardemann
The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions.
Atherosclerosis 1997;130(1-2):203-13.
1997: Michel Marre; X Jeunemaitre; Yves Gallois; Michel Rodier; G Chatellier; C Sert; L Dusselier; Z Kahal; Lucy Chaillous; S Halimi; A Muller; H Sackmann; B Bauduceau; F Bled; Philippe Passa; François Alhenc-Gelas
Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
The Journal of clinical investigation 1997;99(7):1585-95.
1995: M Challah; A Nicoletti; Jean-François Arnal; M Philippe; I Laboulandine; J Allegrini; François Alhenc-Gelas; Sergei M Danilov; Jean-Baptiste Michel
Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension.
Cardiovascular research 1995;30(2):231-9.
1995: E Jaspard; François Alhenc-Gelas
Catalytic properties of the two active sites of angiotensin I-converting enzyme on the cell surface.
Biochemical and biophysical research communications 1995;211(2):528-34.
1994: Jean-François Arnal; T Battle; C Rasetti; M Challah; O Costerousse; E Vicaut; Jean-Baptiste Michel; François Alhenc-Gelas
ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension.
The American journal of physiology 1994;267(5 Pt 2):H1777-84.
1994: J Gardes; M F Gonzalez; François Alhenc-Gelas; J Ménard
Influence of sodium diet on L-NAME effects on renin release and renal vasoconstriction.
The American journal of physiology 1994;267(5 Pt 2):F798-804.
1994: O Costerousse; J Allegrini; H Huang; J Bounhik; François Alhenc-Gelas
Regulation of ACE gene expression and plasma levels during rat postnatal development.
The American journal of physiology 1994;267(5 Pt 1):E745-53.
1994: Sergei M Danilov; E Jaspard; T Churakova; H Towbin; F Savoie; L Wei; François Alhenc-Gelas
Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site.
The Journal of biological chemistry 1994;269(43):26806-14.
1994: H Huang; Jean-François Arnal; Catherine Llorens-Cortes; M Challah; François Alhenc-Gelas; Pierre Corvol; Jean-Baptiste Michel
Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
Circulation research 1994;75(3):454-61.
1993: Florent Soubrier; L Wei; C Hubert; E Clauser; François Alhenc-Gelas; Pierre Corvol
Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications.
Journal of hypertension 1993;11(6):599-604.
1993: E Jaspard; L Wei; François Alhenc-Gelas
Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides.
The Journal of biological chemistry 1993;268(13):9496-503.
1993: Florent Soubrier; C Hubert; P Testut; S Nadaud; François Alhenc-Gelas; Pierre Corvol
Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene.
Journal of hypertension 1993;11(5):471-6.
1993: O Costerousse; J Allegrini; M Lopez; François Alhenc-Gelas
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.
The Biochemical journal 1993;290 ( Pt 1)():33-40.
1992: S Avigdor; François Alhenc-Gelas; J Bouhnik
Effects of thyroid hormones on urinary and renal kallikreins.
The American journal of physiology 1992;263(3 Pt 1):E430-4.
1992: J Bouhnik; J P Richoux; H Huang; F Savoie; Thierry Baussant; François Alhenc-Gelas; Pierre Corvol
Hypertension in Dahl salt-sensitive rats: biochemical and immunohistochemical studies.
Clinical science (London, England : 1979) 1992;83(1):13-22.
1992: S Lesage; J Bouhnik; J P Richoux; Thierry Baussant; F Gauthier; K Eager; Pierre Corvol; François Alhenc-Gelas
Immunological characterization of rat kininogens with monoclonal antibodies to T-kininogen. Distinction between the different domains of T-kininogen and the multiple rat kininogens.
European journal of biochemistry / FEBS 1992;204(2):501-8.
1992: J M Poux; J Gardes; François Alhenc-Gelas; J Menard
[Control of vascular tone by the endothelium: the coupling active vasodilation in the kidney to renin secretion].
Diabète & métabolisme 1992;18(2 Pt 2):145-60.
1992: J Gardes; J M Poux; M F Gonzalez; François Alhenc-Gelas; J Menard
Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney.
Life sciences 1992;50(14):987-93.
1992: J P Richoux; J Bouhnik; G Grignon; François Alhenc-Gelas
Immunolocalization of high molecular weight kininogen (HKg) and T kininogen (TKg) in the rat hypothalamus.
Agents and actions. Supplements 1992;38 ( Pt 1)():627-33.
1992: O Costerousse; E Jaspard; J Allegrini; L Wei; François Alhenc-Gelas
[Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].
Comptes rendus des séances de la Société de biologie et de ses filiales 1992;186(6):586-98.
1992: E Jaspard; O Costerousse; L Wei; Pierre Corvol; François Alhenc-Gelas
The angiotensin I-converting enzyme (kininase II): molecular and regulatory aspects.
Agents and actions. Supplements 1992;38 ( Pt 1)():349-58.
1992: O Costerousse; E Jaspard; L Wei; Pierre Corvol; François Alhenc-Gelas
The angiotensin I-converting enzyme (kininase II): molecular organization and regulation of its expression in humans.
Journal of cardiovascular pharmacology 1992;20 Suppl 9():S10-5.
1991: L Wei; François Alhenc-Gelas; Pierre Corvol; Eric Clauser
The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.
The Journal of biological chemistry 1991;266(14):9002-8.
1991: J L Gelly; J P Richoux; G Grignon; J Bouhnik; Thierry Baussant; François Alhenc-Gelas; Pierre Corvol
Immunocytochemical localization of albumin, transferrin, angiotensinogen and kininogens during the initial stages of the rat liver differentiation.
Histochemistry 1991;96(1):7-12.
1991: J P Richoux; J L Gelly; J Bouhnik; Thierry Baussant; François Alhenc-Gelas; G Grignon; Pierre Corvol
The kallikrein-kinin system in the rat hypothalamus. Immunohistochemical localization of high molecular weight kininogen and T kininogen in different neuronal systems.
Histochemistry 1991;96(3):229-43.
1990: François Alhenc-Gelas; Florent Soubrier; C Hubert; J Allegrini; A L Lattion; Pierre Corvol
The angiotensin I-converting enzyme (kininase II): progress in molecular and genetic structure.
Journal of cardiovascular pharmacology 1990;15 Suppl 6():S25-9.
1989: A L Lattion; Florent Soubrier; J Allegrini; C Hubert; Pierre Corvol; François Alhenc-Gelas
The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme.
FEBS letters 1989;252(1-2):99-104.
1989: J Bouhnik; F Savoie; François Alhenc-Gelas; Thierry Baussant; F Gauthier; Pierre Corvol
Effect of thyroidectomy on rat plasma T-kininogen concentration as demonstrated by a new and direct T-kininogen radioimmunoassay.
Advances in experimental medicine and biology 1989;247B():87-90.
1989: J Bouhnik; F Savoie; A Michaud; Thierry Baussant; François Alhenc-Gelas; Pierre Corvol
Effect of sex hormones on plasma T-kininogen in the rat.
Life sciences 1989;44(24):1859-66.
1988: Florent Soubrier; François Alhenc-Gelas; C Hubert; J Allegrini; M John; G Tregear; Pierre Corvol
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9386-90.
1988: François Cambien; François Alhenc-Gelas; Bernard Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.
American journal of human genetics 1988;43(5):774-80.
1988: A L Lattion; Thierry Baussant; François Alhenc-Gelas; N G Seidah; Pierre Corvol; Florent Soubrier
The high-molecular-mass kininogen deficient rat expresses all kininogen mRNA species, but does not export the high-molecular-mass kininogen synthesized.
FEBS letters 1988;239(1):59-64.
1988: J Bouhnik; F Savoie; Thierry Baussant; A Michaud; François Alhenc-Gelas; Pierre Corvol
Effect of thyroidectomy on rat T-kininogen.
The American journal of physiology 1988;255(4 Pt 1):E411-5.
1988: Thierry Baussant; A Michaud; J Bouhnik; F Savoie; François Alhenc-Gelas; Pierre Corvol
Effect of dexamethasone on kininogen production by a rat hepatoma cell line.
Biochemical and biophysical research communications 1988;154(3):1160-6.
1988: H Suzuki; François Alhenc-Gelas; J Bouhnik; Pierre Corvol; J Ménard
Differential effects of nephrectomy and surgery on plasma kininogens and angiotensinogen in the rat.
Endocrinology 1988;122(6):2809-15.
1985: M L Reis; François Alhenc-Gelas; M Alhenc-Gelas; J Allegrini; D Kerbiriou-Nabias; P Corvol; J Menard
Rat high-molecular-weight kininogen: purification, production of antibodies and demonstration of lack of immunoreactive kininogen in a strain of brown Norway rats.
Biochimica et biophysica acta 1985;831(1):106-13.
1984: François Alhenc-Gelas; T Yasui; J Allegrini; F Pinet; G M Acker; P Corvol; J Ménard
Angiotensin I-converting enzyme in foetal membranes and chorionic cells in culture.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1984;2(3):S247-9.
1984: Jeannine Marchetti; Martine Imbert-Teboul; François Alhenc-Gelas; J Allegrini; J Menard; F Morel
Kallikrein along the rabbit microdissected nephron: a micromethod for its measurement. Effect of adrenalectomy and DOCA treatment.
Pflügers Archiv : European journal of physiology 1984;401(1):27-33.
1981: François Alhenc-Gelas; Jeannine Marchetti; J Allegrini; P Corvol; J Menard
Measurement of urinary kallikrein activity. Species differences in kinin production.
Biochimica et biophysica acta 1981;677(3-4):477-88.